Today I decided to look at some of the terrible observational studies on ivermectin that I've mostly ignored, and wow So far, one with Cohen's d of 2, another with d of 2.9 These are just...gibberish
-
-
I mean, take this trial that I've just found. They report HUGE benefits for ivermectin/ribivarin/nitazoxanide, but it's not randomized and their control group was MUCH MUCH sicker than their interventionhttps://onlinelibrary.wiley.com/doi/10.1002/jmv.26880 …
-
1/3 of the "combined antiviral" group were asymptomatic, compared to just 4% of the control, and the O2 sats were substantially lower in the control at baseline. The study is also problematic in other ways, no one in their right mind would include this in a meta-analysis
- Show replies
New conversation -
-
-
If you’re interested in making another version of that site, perhaps with an overlay of study deficiencies and some sort of corresponding “reliability rating”, let me know.
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
Show additional replies, including those that may contain offensive content
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.